This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Looking for reliable websites to aid your investment learning? Check out our curated list of resources that support new investors on their journey.
28,161 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
DoorDash has become a key player in the on-demand economy. This guide breaks down what to look for, how to evaluate g...
Midas’ mglobal token tracking makes its way onto Aave Horizon as Fasanara unrolls an alternative debt strategy, allow...
Institutional moves can reveal where smart money sees durable cash flow. Learn why ancora advisors opens $148 million...
DeFi hacks pummeled the market in April, sparking a bold security move from the Ethereum community. This article expl...
Portillo's has faced growth and branding challenges that threaten its future. This guide breaks down what a comeback ...
Lucid has dazzled with tech and range, but deep cash burn and production headwinds spark serious questions. Here’s a ...
On March 7, Social Security moves to nationwide support, risking longer waits as offices consolidate. The shift could...
When a high-profile NFL deal blows up in public, it isn’t just about football. It’s a masterclass in money, risk, and...
Aster broadens its partnership with WLFI to introduce USD1-denominated perpetual contracts and new incentives, design...
The FHFA has directed Fannie Mae to accept cryptocurrency as mortgage reserves, but a steep haircut on crypto holding...
The Real Brokerage has added the NŌVEM Real Estate team, broadening its NYC presence across major boroughs and surrou...